N6 ‐Methyladenosine‐Modified circNEK11 Promotes Hepatocellular Carcinoma Progression via the miR ‐1236‐3p/ GPX2 Axis
Open Access
- 24 September 2025
- journal article
- Published by Wiley in Cancer Science
- Vol. 116 (12) , 3326-3336
Abstract
CircRNAs are endogenous covalently closed circular RNAs, and previous studies have validated their key regulatory roles in malignant tumors; however, the specific role and regulatory mechanism of circNEK11 in hepatocellular carcinoma (HCC) remain unclear. Here, we discovered that circNEK11 back‐spliced from exons 12, 13, 14, and 15 of the NEK11 gene is significantly upregulated in HCC tissues, especially recurrent HCC tissues. YTHDC1 functions as a reader of m6A‐modified circNEK11 and facilitates its cytoplasmic export. circNEK11 promotes HCC cell oncogenic functions in vitro and HCC growth in vivo. Mechanistically, circNEK11 directly binds to miR‐1236‐3p to regulate GPX2 expression, thus promoting HCC progression and recurrence. Collectively, our findings suggest that circNEK11 is a potential biomarker and target for HCC diagnosis and treatment.Keywords
Funding Information
- National Natural Science Foundation of China (81902507, 82072646)
This publication has 46 references indexed in Scilit:
- EIF4A3-mediated oncogenic circRNA hsa_circ_0001165 advances esophageal squamous cell carcinoma progression through the miR-381-3p/TNS3 pathwayCell Biology and Toxicology, 2024
- Intron Retention of DDX39A Driven by SNRPD2 is a Crucial Splicing Axis for Oncogenic MYC/Spliceosome Program in Hepatocellular CarcinomaAdvanced Science, 2024
- Role of Wnt/β-catenin pathway in cancer drug resistance: Insights into molecular aspects of major solid tumorsBiochemical and Biophysical Research Communications, 2024
- GPX2 acts as an oncogene and cudraflavone C has an anti-tumor effect by suppressing GPX2-dependent Wnt/β-catenin pathway in colorectal cancer cellsNaunyn-Schmiedeberg's Archives of Pharmacology, 2023
- The beginning of GPX2 and 30 years laterFree Radical Biology and Medicine, 2022
- GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinomaJournal of Advanced Research, 2022
- circVAMP3 Drives CAPRIN1 Phase Separation and Inhibits Hepatocellular Carcinoma by Suppressing c‐Myc TranslationAdvanced Science, 2022
- The Landscape of Circular RNA in CancerCell, 2019
- miR-1236-3p suppresses the migration and invasion by targeting KLF8 in lung adenocarcinoma A549 cellsBiochemical and Biophysical Research Communications, 2017
- Nuclear m6A Reader YTHDC1 Regulates mRNA SplicingMolecular Cell, 2016